FDA Grants Approval for Atomoxetine Hydrochloride ANDA218875
The FDA has granted approval for ANDA218875, a generic version of Atomoxetine Hydrochloride by Creekwood Pharmaceuticals.
Company
Pharmaceutical intelligence for Creekwood Pharmaceuticals with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.